About Us

Zetalix was founded with a singular mission: to bridge the gap between global clinical innovation and India's extraordinary potential as a clinical research destination. As a full-service Clinical Research Organization (CRO), we combine deep scientific expertise, regulatory mastery, and operational discipline to deliver clinical programs that meet the highest international standards.

Our team of clinical researchers, regulatory strategists, biostatisticians, pharmacovigilance specialists, and medical writers works as an integrated extension of our sponsors' teams — providing the local knowledge and global perspective needed to navigate complex development pathways.

We serve pharmaceutical, biotechnology, nutraceutical, and medical device companies across the United States, Europe, Japan, South Korea, the Middle East, and the Asia-Pacific region. Whether you are conducting a first-in-human Phase I trial, seeking generic drug approval through BA/BE studies, or launching a nutraceutical product in the Indian market — Zetalix delivers the clarity, compliance, and speed your program demands.

• Scientific Rigor — Every protocol, dataset, and submission is held to the highest scientific and ethical standards.
• Regulatory Excellence — We don't just comply with regulations; we anticipate them. Our proactive regulatory intelligence keeps your program ahead of evolving guidelines.
• Sponsor-Centric Partnership — Your timelines, your budgets, your therapeutic goals become ours.
• Transparency & Integrity — From cost structures to data quality, we maintain complete transparency.
• Global Standards, Local Expertise — ICH-GCP compliance meets deep, on-the-ground knowledge of India's regulatory and healthcare ecosystem.

• Full-service CRO with end-to-end capabilities — no subcontracting of core functions
• India's regulatory landscape is our home territory
• Therapeutic expertise across oncology, cardiology, CNS, metabolic, respiratory, infectious disease, dermatology, ophthalmology, and more
• Scalable operations — single-site to multi-center national trials
• Dedicated project managers and single point of contact per sponsor
• CDISC-compliant data standards across all studies
• Rapid site activation leveraging established investigator networks